March 30, 2017 UChicago Medicine research finds patients face rising costs for
EpiPen allergy drug Commercially insured patients who use the life - saving epinephrine auto - injector known as «EpiPen» have experienced skyrocketing out - of - pocket costs since 2007, according to research published March 27 in JAMA Internal Medicine.
Not exact matches
TORONTO, April 17 (Reuters)- Canada said on Tuesday it is working with the U.S. Food and
Drug Administration to access supplies of Mylan N.V.'s
EpiPen emergency
allergy antidote amid a global shortage that has spared the United States.
Mylan came under fire in August when it raised the price of the
EpiPen, a lifesaving
allergy drug, to $ 608 for a two - pack.
TORONTO, April 17 - Canada said on Tuesday it is working with the U.S. Food and
Drug Administration to access supplies of Mylan N.V.» s
EpiPen emergency
allergy antidote amid a growing shortage that has spared the United States.
Mylan and federal investigators finalized a $ 465 million settlement of charges the drugmaker overcharged the government for the injection
allergy medication
EpiPen, resolving an issue that fueled nationwide debate over soaring
drug costs.
«I am calling upon him to take those donations out of his $ 27 million campaign coffer and donate them to a worthy institution that treats children with life - threatening
allergies who can't afford
EpiPens or with pediatric cancers like leukemia and Hodgkin's who are suffering because of generic
drug shortages that he causes,» Long said in a statement.
Drug maker Mylan said it will offer a generic version of the life - saving allergy treatment EpiPen for half the list price of the brand - name treatment after it became the center of a national controversy over skyrocketing drug pri
Drug maker Mylan said it will offer a generic version of the life - saving
allergy treatment
EpiPen for half the list price of the brand - name treatment after it became the center of a national controversy over skyrocketing
drug pri
drug prices.